CONTINUATION PAGE: STAY WITHIN MARGINS INDICATED 
2. CHAMPLIN RE, Gale RP. The role of bone marrow transplantation in the treatment of hematologic 
malignancies and solid tumors: a critical review of syngeneic, autologous and allogeneic transplants. 
Cancer Treat Rep. 1984;68:145-161. 
3. CHAMPLIN RE, Kastenberg W, Gale RP. Radiation accidents and nuclear energy: Medical 
consequences and therapy. Ann Intern Med 1988; 109:730-744. 
4. CHAMPLIN RE, Ho WG, Gale RP, et al. Treatment of acute myelogenous leukemia: a prospective 
controlled trial of bone marrow tranplantation versus consolidation chemotherapy. Annals of Internal 
Medicine. 1985;102:285-291. 
5. Winston DJ, Ho WG, Gale RP, CHAMPLIN RE. Prophylaxis of infection in bone marrow transplants. 
Eur J Cancer Clin Oncol 1988; 24(suppl 1):1 5-23. 
6. CHAMPLIN RE, Gale RP. Acute lymphoblastic leukemia: recent advances in biology and therapy. 
Blood 1989; 73:2051-2066. 
7. Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, CHAMPLIN R. Molecular relapse in chronic 
myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. 
Proc Natl Acad Sci USA. 1990;87:563-567. 
8. CHAMPLIN RE, Nimer SD, Ireland P, Oette DH, Golde DW. Treatment of refractory aplastic anemia 
with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 73:694-699. 
9. CHAMPLIN R. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation. 
Hematol Oncol Clin North Am. 1990;4:687-698. 
10. Gajewski J, Ho WG, Nimer S, Hirji KF, Jacobs A, CHAMPLIN RE. Efficacy of intensive 
chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J Clin Oncol 
1989; 7:1637-1645. 
11. Gajewski JL, Ho WG, Feig SA, Hunt L, Kaufman N, CHAMPLIN RE. Bone marrow transplantation 
using unrelated donors for patients with advanced leukemia or bone marrow failure. Transplantation 
1990; 50:244-249. 
12. CHAMPLIN RE, Ho WG, Gajewski J, Feig S, Burnison M, Holley G, Greenberg P, Lee K, Schmid I, 
Giorgi J, Yam P, Petz L, Winston D, Warner N, Reichert T. Selective depletion of CD8 positive 
T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow 
transplantation. Blood 1990; 76:418-423. 
13. CHAMPLIN RE, Jansen J, Ho W, Gajewski J, Nimer S, Lee K, Territo M, Winston D, Tricot G, 
Reichert T. Retention of graft-versus-host-leukemia using selective depletion of CD8-positive-T- 
lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for 
chronic myelogenous leukemia. Transplant Proc, 1991; 23:1695-1696. 
14. CHAMPLIN" RE. Therapeutic use of hematopoietic growth factors in bone marrow transplantation. 
Cancer Bulletin, 1 99 1 ; 43: 1 97-207. 
15. Ugozzoli L, Yam P, Petz LD, Ferrara GB, CHAMPLIN RE, Forman SJ, Koyal D, Wallace RB: 
Amplification by the polymerase chain reaction of hypervariable regions of the human genome for 
evaluation of chimerism after bone marrow transplantation. Blood 1991; 77:1607-1615. 
16. Nimer SD, Golde DW, Kwan K, Lee K, Clark S, CHAMPLIN RE. In vitro production of granulocyte- 
macrophage colony-stimulating factor in aplastic anemia: Possible mechanisms of action of 
antithymocyte globulin. Blood 1991; 78:163-168. 
(Rev ‘ 9/91 } . Page ^ 
u.-noof pages consecutive ty a the bottom throughout the application. Do not use suffixes such as 3a, 3b. 
Recombinant DNA Research, Volume 17 
[683] 
